A Study to Learn About the Study Medicine PF-08052667 in People With Bladder Cancer
The purpose of this study is to learn how a new medicine called PF-08052667 works when
used by itself or together with another medicine called Bacillus Calmette Guerin (BCG),
and/or a medicine called sasanlimab.
This study is for adults who have a type of bladder c...
Age: 18 years - 66+
Gender: All
Feasibility of Timesaving When Using Histolog Confocal Laser Endomicroscopy for Margin Assessment in Prostatectomy Specimen
This study investigates a new, faster way to find cancer cells on the surface of the
prostate during radical prostatectomy surgery. A recently FDA-approved device, called the
Histolog Scanner, gives high-resolution imaging of the surface of fresh tissue using
ultra-f...
Age: 18 years - 66+
Gender: Male
A Study to Evaluate INCA035784 in Participants With Myeloproliferative Neoplasms
This study is being conducted to evaluate the safety and tolerability of INCA035784 in
participants with myeloproliferative neoplasms.
Age: 18 years - 66+
Gender: All
Study of IgPro20 to Prevent Infection in People With Multiple Myeloma and Hypogammaglobulinemia
The main purpose of this study is to see if IgPro20 can prevent infection in people with
multiple myeloma (MM) who have hypogammaglobulinemia from receiving bispecific monoclonal
antibodies (BsAbs).
Age: 18 years - 66+
Gender: All
Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer
This phase III trial compares the effect of dose-escalated radiation therapy to usual
care in patients with locally advanced unresectable pancreatic ductal adenocarcinoma who
have received an initial 4-6 months of chemotherapy. Usual care options include
additional c...
Age: 18 years - 66+
Gender: All
A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)
Researchers are looking for new ways to treat metastatic castration-resistant prostate
cancer (mCRPC). Researchers have designed a study medicine called ifinatamab deruxtecan
(also called I-DXd or MK-2400) to treat mCRPC. The goal of this study is to learn if
people ...
Age: 18 years - 66+
Gender: Male
Pleuroscopy First Versus Thoracentesis First in Patients with Suspected Malignant Pleural Effusions
This is a randomized control trial of patients with suspected malignant pleural effusions
to compare whether patients who have a thoracentesis or pleuroscopy (pleural biopsy)
obtain an adequate biopsy, achieve a diagnosis, and begin cancer-directed therapy faster.
Age: 18 years - 66+
Gender: All
Study of Zelenectide Pevedotin in Participants With Advanced Breast Cancer
This is a global, multicenter, open-label study that aims to assess the efficacy and
safety of zelenectide pevedotin in participants with NECTIN4-amplified recurrent,
unresectable, or metastatic breast cancer who have received prior therapy (see inclusion
criteria be...
Age: 18 years - 66+
Gender: All
Subcutaneous Talquetamab in Elderly Patients With Multiple Myeloma in Early Relapse
Induction therapy approaches in recent years have evolved, now utilizing triple or
quadruple drug regimens in the majority of patients. By combining anti-CD38 antibodies,
proteasome inhibitors (PIs), immunomodulatory drugs (IMiDs), and steroids, patients
achieve long...
Age: 70 years - 66+
Gender: All
Safety and Tolerability of IPH4502 in Patients With Advanced Solid Tumors
This is a first-in-human, open-label, multicenter, Phase 1 study to evaluate the safety,
tolerability and preliminary efficacy of IPH4502 and to determine the recommended Phase 2
dose (RP2D) in advanced solid tumors that are known to express Nectin-4
Age: 18 years - 66+
Gender: All
Safety and Tolerability of IPH4502 in Patients With Advanced Solid Tumors
This is a first-in-human, open-label, multicenter, Phase 1 study to evaluate the safety,
tolerability and preliminary efficacy of IPH4502 and to determine the recommended Phase 2
dose (RP2D) in advanced solid tumors that are known to express Nectin-4
Age: 18 years - 66+
Gender: All
A Study to Compare the Efficacy and Safety of BMS-986365 Versus the Investigator's Choice of Therapy in Participants With Metastatic Castration-resistant Prostate Cancer
The purpose of this study is to compare the efficacy and safety of BMS-986365 versus the
investigator's choice of therapy in participants with Metastatic Castration-resistant
Prostate Cancer.
Age: 18 years - 66+
Gender: Male
A Study to Compare the Efficacy and Safety of BMS-986365 Versus the Investigator's Choice of Therapy in Participants With Metastatic Castration-resistant Prostate Cancer
The purpose of this study is to compare the efficacy and safety of BMS-986365 versus the
investigator's choice of therapy in participants with Metastatic Castration-resistant
Prostate Cancer.
Age: 18 years - 66+
Gender: Male
E-Mindfulness Approaches for Living After Breast Cancer
NRG-CC015 is a prospective, randomized phase III clinical trial to evaluate the efficacy
of two distinct digital approaches for delivering a mindfulness-based intervention: a
live, instructor-led version delivered over Zoom (MAPs LO), and an app-based, self-paced
ver...
Age: 18 - 50 years
Gender: All
Genomic and Methylation Markers in SCLC and LCNEC for Chemo-Immunotherapy Resistance Prediction (STRATUS)
The goal of this observational study is to understand how genomic and epigenetic factors
contribute to resistance against chemo-immunotherapy in adults diagnosed with
extensive-stage small cell lung cancer (ES-SCLC) or metastatic large cell neuroendocrine
carcinoma (...
Age: 18 - 85 years
Gender: All
Genomic and Methylation Markers in SCLC and LCNEC for Chemo-Immunotherapy Resistance Prediction (STRATUS)
The goal of this observational study is to understand how genomic and epigenetic factors
contribute to resistance against chemo-immunotherapy in adults diagnosed with
extensive-stage small cell lung cancer (ES-SCLC) or metastatic large cell neuroendocrine
carcinoma (...
Age: 18 - 85 years
Gender: All
Chlorhexidine Antiseptic Irrigation of the Bowel Segment During Radical Cystectomy and Urinary Diversion
This is a single arm, interventional pilot study of using chlorhexidine irrigation
intra-operatively and post-operatively among patients undergoing radical cystectomy with
urinary diversion. The intervention comprises of using irrigation of ileal conduit or
ileal neo...
Age: 18 years - 66+
Gender: All
Chlorhexidine Antiseptic Irrigation of the Bowel Segment During Radical Cystectomy and Urinary Diversion
This is a single arm, interventional pilot study of using chlorhexidine irrigation
intra-operatively and post-operatively among patients undergoing radical cystectomy with
urinary diversion. The intervention comprises of using irrigation of ileal conduit or
ileal neo...
Age: 18 years - 66+
Gender: All
Testing the Addition of the Anti-Cancer Drug Tivozanib to Immunotherapy (Pembrolizumab) After Surgery to Remove All Known Sites of Kidney Cancer
This phase III trial compares the effect of adding tivozanib to standard therapy pembrolizumab versus pembrolizumab alone for the treatment of patients with high-risk renal cell carcinoma (RCC). Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help t...
Age: 18 years - 66+
Gender: All
WATER IV Prostate Cancer
This is a multicenter, prospective, randomized clinical trial that aims to assess the
safety and efficacy of Aquablation Therapy in men with low-risk to intermediate to
high-risk localized prostate cancer who are candidates for, or have opted for,
prostatectomy. Part...
Age: 45 years - 66+
Gender: Male